Challenges in shared decision making in advanced cancer care: a qualitative longitudinal observational and interview study

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Background: Patients' preferences and expectations should be taken into account in treatment decision making in the last phase of life. Shared decision making (SDM) is regarded as a way to give the patient a central role in decision making. Little is known about how SDM is used in clinical practice in advanced cancer care. Objective: To examine whether and how the steps of SDM can be recognized in decision making about second- and third-line chemotherapy. Methods: Fourteen advanced cancer patients were followed over time using face-to-face in-depth interviews and observations of the patients' out-clinic visits. Interviews and outpatient clinic visits in which treatment options were discussed or decisions made were transcribed verbatim and analysed using open coding. Results: Patients were satisfied with the decision-making process, but the steps of SDM were barely seen in daily practice. The creation of awareness about available treatment options by physicians was limited and not discussed in an equal way. Patients' wishes and concerns were not explicitly assessed, which led to different expectations about improved survival from subsequent lines of chemotherapy. Conclusion: To reach SDM in daily practice, physicians should create awareness of all treatment options, including forgoing treatment, and communicate the risk of benefit and harm. Open and honest communication is needed in which patients' expectations and concerns are discussed. Through this, the difficult process of decision making in the last phase of life can be facilitated and the focus on the best care for the specific patient is strengthened.

Original languageEnglish
Pages (from-to)69-84
Number of pages16
JournalHealth Expectations
Volume20
Issue number1
DOIs
Publication statusPublished - 1 Feb 2017

Cite this

@article{75d0dea0edff4479ab3e32c5c92dbe6f,
title = "Challenges in shared decision making in advanced cancer care: a qualitative longitudinal observational and interview study",
abstract = "Background: Patients' preferences and expectations should be taken into account in treatment decision making in the last phase of life. Shared decision making (SDM) is regarded as a way to give the patient a central role in decision making. Little is known about how SDM is used in clinical practice in advanced cancer care. Objective: To examine whether and how the steps of SDM can be recognized in decision making about second- and third-line chemotherapy. Methods: Fourteen advanced cancer patients were followed over time using face-to-face in-depth interviews and observations of the patients' out-clinic visits. Interviews and outpatient clinic visits in which treatment options were discussed or decisions made were transcribed verbatim and analysed using open coding. Results: Patients were satisfied with the decision-making process, but the steps of SDM were barely seen in daily practice. The creation of awareness about available treatment options by physicians was limited and not discussed in an equal way. Patients' wishes and concerns were not explicitly assessed, which led to different expectations about improved survival from subsequent lines of chemotherapy. Conclusion: To reach SDM in daily practice, physicians should create awareness of all treatment options, including forgoing treatment, and communicate the risk of benefit and harm. Open and honest communication is needed in which patients' expectations and concerns are discussed. Through this, the difficult process of decision making in the last phase of life can be facilitated and the focus on the best care for the specific patient is strengthened.",
keywords = "communication, end of life, patient participation, shared decision making, treatment options",
author = "Linda Brom and {De Snoo-Trimp}, {Janine C.} and Onwuteaka-Philipsen, {Bregje D.} and Widdershoven, {Guy A.M.} and Stiggelbout, {Anne M.} and Pasman, {H. Roeline W.}",
year = "2017",
month = "2",
day = "1",
doi = "10.1111/hex.12434",
language = "English",
volume = "20",
pages = "69--84",
journal = "Health Expectations",
issn = "1369-6513",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Challenges in shared decision making in advanced cancer care

T2 - a qualitative longitudinal observational and interview study

AU - Brom, Linda

AU - De Snoo-Trimp, Janine C.

AU - Onwuteaka-Philipsen, Bregje D.

AU - Widdershoven, Guy A.M.

AU - Stiggelbout, Anne M.

AU - Pasman, H. Roeline W.

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Background: Patients' preferences and expectations should be taken into account in treatment decision making in the last phase of life. Shared decision making (SDM) is regarded as a way to give the patient a central role in decision making. Little is known about how SDM is used in clinical practice in advanced cancer care. Objective: To examine whether and how the steps of SDM can be recognized in decision making about second- and third-line chemotherapy. Methods: Fourteen advanced cancer patients were followed over time using face-to-face in-depth interviews and observations of the patients' out-clinic visits. Interviews and outpatient clinic visits in which treatment options were discussed or decisions made were transcribed verbatim and analysed using open coding. Results: Patients were satisfied with the decision-making process, but the steps of SDM were barely seen in daily practice. The creation of awareness about available treatment options by physicians was limited and not discussed in an equal way. Patients' wishes and concerns were not explicitly assessed, which led to different expectations about improved survival from subsequent lines of chemotherapy. Conclusion: To reach SDM in daily practice, physicians should create awareness of all treatment options, including forgoing treatment, and communicate the risk of benefit and harm. Open and honest communication is needed in which patients' expectations and concerns are discussed. Through this, the difficult process of decision making in the last phase of life can be facilitated and the focus on the best care for the specific patient is strengthened.

AB - Background: Patients' preferences and expectations should be taken into account in treatment decision making in the last phase of life. Shared decision making (SDM) is regarded as a way to give the patient a central role in decision making. Little is known about how SDM is used in clinical practice in advanced cancer care. Objective: To examine whether and how the steps of SDM can be recognized in decision making about second- and third-line chemotherapy. Methods: Fourteen advanced cancer patients were followed over time using face-to-face in-depth interviews and observations of the patients' out-clinic visits. Interviews and outpatient clinic visits in which treatment options were discussed or decisions made were transcribed verbatim and analysed using open coding. Results: Patients were satisfied with the decision-making process, but the steps of SDM were barely seen in daily practice. The creation of awareness about available treatment options by physicians was limited and not discussed in an equal way. Patients' wishes and concerns were not explicitly assessed, which led to different expectations about improved survival from subsequent lines of chemotherapy. Conclusion: To reach SDM in daily practice, physicians should create awareness of all treatment options, including forgoing treatment, and communicate the risk of benefit and harm. Open and honest communication is needed in which patients' expectations and concerns are discussed. Through this, the difficult process of decision making in the last phase of life can be facilitated and the focus on the best care for the specific patient is strengthened.

KW - communication

KW - end of life

KW - patient participation

KW - shared decision making

KW - treatment options

UR - http://www.scopus.com/inward/record.url?scp=84950349837&partnerID=8YFLogxK

U2 - 10.1111/hex.12434

DO - 10.1111/hex.12434

M3 - Article

VL - 20

SP - 69

EP - 84

JO - Health Expectations

JF - Health Expectations

SN - 1369-6513

IS - 1

ER -